Evidence-Based Wellness

Health journalism
that feels curated,
not crowded.

Research-led nutrition, recovery, and longevity coverage with a quieter visual language and clearer hierarchy.

This Week

Peptides, recovery protocols, and practical interpretation.

Editor's Note

Better pacing, less filler, and just enough imagery to support the text.

Sections

Browse the index

View Full Archive
Latest Findings

New in the journal

Retatrutide in 2026: What the Data Actually Show
Mar 22, 202601

Retatrutide in 2026: What the Data Actually Show

Retatrutide is getting attention because the weight-loss numbers look big. Here is what matters if you actually want to understand how it works, what the data show, and what to watch before you get excited.

Dr. Aris ThorneRead
CJC-1295 Explained: GH, IGF-1, and the Regulatory Problem
Mar 20, 202602

CJC-1295 Explained: GH, IGF-1, and the Regulatory Problem

CJC-1295 gets sold as a shortcut to higher growth hormone and better recovery. The useful question is simpler: what does it really do, what can users realistically expect, and where do the weak spots show up?

Dr. Aris ThorneRead
Peptides for Recovery: Where the Evidence Gets Thin
Mar 18, 202603

Peptides for Recovery: Where the Evidence Gets Thin

Recovery peptides sound clean and precise, which is why so many lifters and active people want them. The harder question is which claims hold up when you stop reading product pages and start looking for usable evidence.

Dr. Aris ThorneRead
Scientific Dispatch

Bi-weekly insights with a sharper editorial point of view.

Join practitioners and readers who want concise breakdowns, cleaner design, and stronger curation.

Newsletter signup coming soon
Retatrutide in 2026: What the Data Actually Show
From the journal

Retatrutide in 2026: What the Data Actually Show